{
    "2021-04-16": [
        [
            {
                "time": "",
                "original_text": "健帆生物(300529.SZ)：48.64万份“健帆JLC2”采用自主行权模式",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "300529.SZ",
                        "48.64万份",
                        "健帆JLC2",
                        "自主行权"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "健帆生物(300529.SZ)：134.16万份“健帆JLC3”采用自主行权模式",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "300529.SZ",
                        "134.16万份",
                        "健帆JLC3",
                        "自主行权"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "健帆生物(300529.SZ)：278.76万份“健帆JLC4”采用自主行权模式",
                "features": {
                    "keywords": [
                        "健帆生物",
                        "300529.SZ",
                        "278.76万份",
                        "健帆JLC4",
                        "自主行权"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "高瓴资本概念股多数逆势下滑，恩捷、国瓷、泰格、健帆、广联达等跌幅居前",
                "features": {
                    "keywords": [
                        "高瓴资本",
                        "概念股",
                        "逆势下滑",
                        "恩捷",
                        "国瓷",
                        "泰格",
                        "健帆",
                        "广联达"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "科技",
                        "材料"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}